Cargando…
Evaluation of therapeutic effects of (125)I particles brachytherapy for recurrent bladder cancer
The aim of the present study was to evaluate the clinical value of (125)I particles implantation in the treatment of recurrent bladder cancer. The study is a retrospective analysis of 32 patients with recurrent bladder cancer treated between May 2010 and January 2010. Of these, 16 cases (chemotherap...
Autores principales: | Zhou, Yu-Ming, Feng, Xiao, Zhou, Bing-Cheng, Fan, Yue-Feng, Huang, Yuan-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778877/ https://www.ncbi.nlm.nih.gov/pubmed/29435083 http://dx.doi.org/10.3892/ol.2017.7723 |
Ejemplares similares
-
CT-guided (125)I brachytherapy for recurrent ovarian cancer
por: Liu, Ping, et al.
Publicado: (2017) -
Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Jiang, Qin, et al.
Publicado: (2021) -
CT-guided (125)I brachytherapy for locally recurrent nasopharyngeal carcinoma
por: Yan, Huzheng, et al.
Publicado: (2017) -
Therapeutic effects and prognostic factors of (125)I brachytherapy for pelvic recurrence after early cervical cancer surgery
por: Wang, Rui, et al.
Publicado: (2021) -
A novel three-dimensional template combined with MR-guided (125)I brachytherapy for recurrent glioblastoma
por: He, Xiangmeng, et al.
Publicado: (2020)